Lp-PLA2 IS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR EVENTS IN DIALYZED PATIENTS

被引：0
|
作者：
De Mauri, Andreana [1 ,3 ]
Vidali, Matteo [4 ]
Rolla, Roberta [1 ,2 ]
Brustia, Maddalena [3 ]
David, Paola [3 ]
Ruva, Carlo [3 ]
Capurro, Federica [3 ]
Chiarinotti, Doriana [3 ]
Bellomo, Giorgio [1 ,2 ]
机构：
[1] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy
[2] Maggiore Carita Univ Hosp, Clin Chem Lab, Novara, Italy
[3] Maggiore Carita Univ Hosp, Nephrol & Dialysis Unit, Novara, Italy
[4] SS Trinita Hosp, Immunohematol & Transfus Med Unit, Borgomanero, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MP742
引用
收藏
页码：706 / 706
页数：1
相关论文
共 50 条
  • [21] Lipoprotein-associated phospholipase A2 (Lp-PLa2) is an independent predictor of adverse cardiovascular outcomes in patients with stable coronary artery disease
    Sabatine, Marc S.
    Morrow, David A.
    O'Donoghue, Michelle
    Jablonski, Kathleen A.
    Rice, Madeline M.
    Solomon, Scott D.
    Rosenberg, Yves D.
    Domanski, Michael J.
    Hsia, Judith
    CIRCULATION, 2006, 114 (18) : 713 - 713
  • [22] Val279Phe variant of Lp-PLA2 is a risk factor for a subpopulation of Indonesia patients with acute myocardial infarction
    Cahyaningtias, Miryanti
    Rohman, Mohammad Saifur
    Widodo
    Adi, Andi Wahjono
    Yuda, Rina
    Indrayana, Yanna
    Putri, Jayarani Fatimah
    Rusdianto
    Lukitasari, Mifetika
    Hendrawan, Dadang
    GENES & DISEASES, 2016, 3 (04) : 289 - 293
  • [23] Lp-PLA2:: A new kid on the block
    Zalewski, Andrew
    Nelson, Jeanenne J.
    Hegg, Lisa
    Macphee, Colin
    CLINICAL CHEMISTRY, 2006, 52 (09) : 1645 - 1650
  • [24] The Association Between Lipoprotein Associated Phospholipase A2 (Lp-PLA2) and Cardiovascular Disease Risk in an Irish Population
    Dunleavy, E.
    Louw, M.
    Mason, J.
    Rochev, Y.
    Hutchinson, K.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2013, 182 : S405 - S405
  • [25] Heritability of Plasma Lipoprotein-associated Phospholipase A2 (Lp-PLA2), a new marker of cardiovascular risk
    Lenzini, L.
    Caroccia, B.
    Wolfert, R.
    Szczech, R.
    Cesari, M.
    Narkiewicz, K.
    Williams, C. J.
    Rossi, G. P.
    HYPERTENSION, 2008, 52 (04) : 764 - 764
  • [26] LP-PLA2 LEVELS ARE INDEPENDANT OF STATIN TREATMENT IN DYSLIPIDEMIC PATIENTS
    Rosenbaum, D.
    Mattina, A.
    Bittar, R.
    Bruckert, E.
    Rousselot, D. Bonnefont
    Giral, P.
    ATHEROSCLEROSIS, 2015, 241 (01) : E109 - E109
  • [27] Lp-PLA2 as a promising predictor of comorbidities in patients with severe psoriasis
    Kiluk, Paulina
    Baran, Anna
    Swiderska, Magdalena
    Maciaszek, Magdalena
    Flisiak, Iwona
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2020, 31 (05) : 524 - 530
  • [28] The Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Gene is Associated With Plasma Lp-PLA2 Mass and Activity
    Holkanson, John E.
    Kinney, Gregory L.
    Snell-Bergeon, Janet K.
    Rewers, Marian
    CIRCULATION, 2009, 120 (18) : S606 - S606
  • [29] Lp-PLA2 gene polymorphisms, plasma levels of Lp-PLA2, and risk of coronary heart disease: Results from a large case-control study
    Khuseyinova, N
    Rothenbacher, D
    Hoffmann, MM
    Brenner, H
    Koenig, W
    CIRCULATION, 2006, 113 (08) : E322 - E322
  • [30] Metalloproteases 2 and 9, Lp-PLA2 and Lipoprotein Profile in Coronary Patients
    Luz Muzzio, Maria
    Miksztowlcz, Veronica
    Brites, Fernando
    Aguilar, Daniel
    Martin Repetto, Esteban
    Wikinski, Regina
    Tavella, Marcelo
    Schreier, Laura
    Alicia Berg, Gabriela
    ARCHIVES OF MEDICAL RESEARCH, 2009, 40 (01) : 48 - 53
12345